Organon (OGN) Cash from Investing Activities (2020 - 2026)

Organon's Cash from Investing Activities history runs 7 years deep, the most recent figure standing at $386.0 million for Q1 2026.

• In Q1 2026, Cash from Investing Activities rose 324.42% year-over-year to $386.0 million; the TTM figure through Mar 2026 stood at $168.0 million (up 128.52% YoY), while the FY2025 annual figure was -$390.0 million, up 23.98% from the prior year.
• Cash from Investing Activities was $386.0 million for Q1 2026 at Organon, up from -$65.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $386.0 million in Q1 2026 to a low of -$296.0 million in Q4 2024.
• Historically, Cash from Investing Activities has averaged -$70.4 million across 5 years, with a median of -$70.0 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Cash from Investing Activities plunged 265.43% in 2024, then soared 324.42% in 2026.
• A 5-year view of Cash from Investing Activities shows it stood at -$61.0 million in 2022, then slumped by 32.79% to -$81.0 million in 2023, then slumped by 265.43% to -$296.0 million in 2024, then soared by 78.04% to -$65.0 million in 2025, then soared by 693.85% to $386.0 million in 2026.
• The last three Cash from Investing Activities figures came in at $386.0 million (Q1 2026), -$65.0 million (Q4 2025), and -$115.0 million (Q3 2025), per Business Quant data.